

A practical guide for providers on helping patients locate Aluminum Chloride (Drysol) when pharmacies are out of stock. Includes 5 actionable steps and alternatives.
You prescribe Aluminum Chloride Hexahydrate for a patient with hyperhidrosis. Two days later, they call back: their pharmacy doesn't have it, and neither does the one down the street. This scenario has become increasingly common, and it's a problem that affects patient outcomes, trust, and compliance.
As a provider, you have more leverage than your patients do when it comes to navigating medication availability. This guide gives you five concrete steps to help your patients find Aluminum Chloride in stock, plus a framework for when it makes sense to switch to an alternative.
As of early 2026, Aluminum Chloride Hexahydrate is not on the FDA or ASHP drug shortage lists. Person & Covey continues to manufacture Drysol, and generic versions remain in production. The issue is not a true shortage but rather a distribution and stocking problem:
For a more detailed supply analysis, see our provider shortage briefing.
Understanding the patient experience is key to helping effectively. Here's what your patients typically encounter:
By intervening proactively at the prescribing stage, you can short-circuit this frustrating cycle.
Use Medfinder for Providers to check which pharmacies near your patient's home or office have Aluminum Chloride in stock. This takes under a minute and dramatically improves the chance of a successful fill on the first try.
Send the prescription directly to a pharmacy you've confirmed has the medication in stock.
Write the prescription as "Aluminum Chloride Hexahydrate 20% topical solution" rather than specifying Drysol. This gives the pharmacy flexibility to dispense any available manufacturer's product. Ensure DAW (Dispense As Written) is set to 0 to allow substitution.
Identify 1-2 compounding pharmacies in your area that can prepare Aluminum Chloride solutions. Because the formulation is straightforward — aluminum chloride hexahydrate dissolved in anhydrous ethanol — most compounding pharmacies can prepare it quickly and affordably ($15 to $40).
Keep these pharmacy names and fax numbers in your EHR system or prescribing workflow so you can redirect prescriptions quickly when retail pharmacies are out of stock.
Give patients a handout or direct them to resources that explain:
You can share our patient-facing guide: How to Find Aluminum Chloride in Stock Near You.
For patients whose insurance denies coverage of Aluminum Chloride as "cosmetic," providing a letter of medical necessity that documents the diagnosis of hyperhidrosis (ICD-10: R61) and functional impairment can help with appeals. While the cash price is low ($10-$35), some patients are on fixed incomes or have high medication burdens where every dollar matters.
If Aluminum Chloride is genuinely unavailable or if the patient has had an inadequate response, consider these evidence-based alternatives:
For a patient-friendly comparison, share our alternatives guide.
Integrating these strategies into your daily workflow doesn't have to be time-consuming:
Aluminum Chloride is effective, affordable, and well-tolerated — which makes it all the more frustrating when patients can't find it. By checking availability proactively, prescribing generically, maintaining compounding pharmacy relationships, and equipping patients with the right tools, you can significantly reduce the access gap.
Your patients depend on you not just for the prescription, but for the guidance to fill it. A few extra minutes at the prescribing stage can save them hours of frustration and keep them on the treatment that works.
For more resources, visit Medfinder for Providers and explore our provider shortage briefing.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.